LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
DexCom
DXCM
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Constellation Brands
STZ
(Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 61.62%40.8M | -16.84%20.14M | -58.46%16.15M | -36.36%18.5M | -36.36%18.5M | -44.31%25.25M | -38.93%24.21M | -21.08%38.87M | -12.91%29.07M | -12.91%29.07M |
-Cash and cash equivalents | 61.62%40.8M | -16.84%20.14M | -58.46%16.15M | -36.36%18.5M | -36.36%18.5M | -44.31%25.25M | -38.93%24.21M | -21.08%38.87M | -12.91%29.07M | -12.91%29.07M |
Receivables | -1.49%468.55M | -4.72%380.96M | -5.22%340.08M | 5.13%402.41M | 5.13%402.41M | -7.18%475.63M | -23.15%399.85M | -26.42%358.82M | -17.34%382.76M | -17.34%382.76M |
-Accounts receivable | -1.54%456.17M | -5.63%365.68M | -6.18%328.1M | 4.48%394.54M | 4.48%394.54M | -8.35%463.32M | -23.61%387.5M | -26.52%349.7M | -17.49%377.6M | -17.49%377.6M |
-Taxes receivable | 0.59%12.38M | 23.81%15.29M | 31.38%11.98M | 52.66%7.87M | 52.66%7.87M | 79.25%12.31M | -5.49%12.35M | -22.38%9.12M | -5.01%5.16M | -5.01%5.16M |
Inventory | 5.80%450.74M | 7.79%469.63M | 2.50%444.75M | -13.06%396M | -13.06%396M | -20.63%426.03M | -32.26%435.68M | -29.29%433.91M | -18.37%455.49M | -18.37%455.49M |
Other current assets | 22.62%36.22M | 3.31%29.91M | 25.07%30.59M | 9.27%27.01M | 9.27%27.01M | 6.05%29.54M | -16.44%28.95M | -5.82%24.46M | -3.85%24.72M | -3.85%24.72M |
Total current assets | 4.17%996.31M | 1.34%900.64M | -2.86%831.56M | -5.39%843.92M | -5.39%843.92M | -14.79%956.44M | -28.20%888.69M | -27.24%856.06M | -17.56%892.04M | -17.56%892.04M |
Non current assets | ||||||||||
Net PPE | -1.97%365.88M | -2.06%366.2M | -5.17%371.3M | -4.59%372.61M | -4.59%372.61M | -0.47%373.23M | 7.67%373.9M | 21.11%391.56M | 60.63%390.54M | 60.63%390.54M |
-Gross PPE | 4.35%558.75M | 4.22%552.69M | -4.67%549.62M | -4.89%541.63M | -4.89%541.63M | -2.53%535.44M | 1.81%530.31M | 17.55%576.53M | 40.92%569.51M | 40.92%569.51M |
-Accumulated depreciation | -18.90%-192.87M | -19.23%-186.49M | 3.60%-178.32M | 5.55%-169.02M | 5.55%-169.02M | 6.97%-162.21M | 9.91%-156.41M | -10.66%-184.97M | -11.15%-178.96M | -11.15%-178.96M |
Goodwill and other intangible assets | -1.05%1.59B | -1.02%1.6B | -1.05%1.6B | -1.05%1.6B | -1.05%1.6B | -0.86%1.61B | -1.00%1.61B | -0.99%1.62B | 8.99%1.62B | 8.99%1.62B |
-Goodwill | 0.00%1.07B | 0.00%1.07B | 0.00%1.07B | 0.02%1.07B | 0.02%1.07B | 0.32%1.07B | 0.14%1.07B | 0.15%1.07B | 12.39%1.07B | 12.39%1.07B |
-Other intangible assets | -3.13%524.11M | -3.02%528.51M | -3.09%532.38M | -3.10%536.7M | -3.10%536.7M | -3.10%541.06M | -3.16%544.96M | -3.13%549.38M | 2.98%553.88M | 2.98%553.88M |
Non current deferred assets | 9.66%3.26M | 27.20%3.81M | 37.14%3.78M | 31.68%3.66M | 31.68%3.66M | 13.44%2.97M | 12.76%3M | -28.89%2.76M | -23.35%2.78M | -23.35%2.78M |
Other non current assets | 42.19%16.85M | -40.58%14.49M | 139.22%15.2M | 87.91%15.01M | 87.91%15.01M | 53.44%11.85M | 156.90%24.38M | -23.97%6.35M | 1.27%7.99M | 1.27%7.99M |
Total non current assets | -0.95%1.98B | -1.65%1.98B | -1.36%1.99B | -1.33%1.99B | -1.33%1.99B | -0.56%2B | 1.29%2.01B | 2.49%2.02B | 16.10%2.02B | 16.10%2.02B |
Total assets | 0.71%2.97B | -0.73%2.88B | -1.81%2.82B | -2.58%2.84B | -2.58%2.84B | -5.66%2.95B | -10.03%2.9B | -8.63%2.87B | 3.20%2.91B | 3.20%2.91B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 0.49%345.54M | 17.90%356.94M | 3.65%274.7M | 34.56%299.74M | 34.56%299.74M | 27.80%343.87M | -12.94%302.75M | -28.05%265.03M | -42.04%222.76M | -42.04%222.76M |
-accounts payable | 7.61%315.35M | 24.97%323.26M | 8.41%245.22M | 28.73%245.35M | 28.73%245.35M | 26.06%293.05M | -16.99%258.67M | -30.00%226.19M | -38.15%190.6M | -38.15%190.6M |
-Total tax payable | -40.59%30.19M | -23.58%33.68M | -24.08%29.49M | 69.14%54.39M | 69.14%54.39M | 38.78%50.82M | 22.01%44.08M | -14.18%38.84M | -57.76%32.16M | -57.76%32.16M |
Current accrued expenses | -18.18%105.62M | -17.59%88.4M | -24.06%87M | -31.68%88.35M | -31.68%88.35M | -21.83%129.08M | -31.51%107.26M | -28.28%114.56M | -18.30%129.31M | -18.30%129.31M |
Current debt and capital lease obligation | 37.83%8.59M | 25.31%7.81M | 12.77%7.03M | 3.07%6.25M | 3.07%6.25M | -70.13%6.24M | -70.13%6.24M | -57.36%6.24M | 221.87%6.06M | 221.87%6.06M |
-Current debt | 37.83%8.59M | 25.31%7.81M | 12.77%7.03M | 3.07%6.25M | 3.07%6.25M | -70.13%6.24M | -70.13%6.24M | -57.36%6.24M | 221.87%6.06M | 221.87%6.06M |
Other current liabilities | -10.10%58.02M | -1.08%55.55M | 7.23%58.94M | 4.53%56.47M | 4.53%56.47M | -4.56%64.54M | -2.99%56.15M | -9.32%54.97M | -7.21%54.03M | -7.21%54.03M |
Current liabilities | -4.77%517.77M | 7.68%508.7M | -2.98%427.68M | 9.38%450.81M | 9.38%450.81M | 4.02%543.72M | -18.99%472.4M | -26.94%440.79M | -31.61%412.16M | -31.61%412.16M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -0.33%766.16M | -15.60%742.48M | -10.62%779.59M | -28.25%696.68M | -28.25%696.68M | -30.37%768.67M | -26.35%879.7M | -23.37%872.24M | 13.56%971.02M | 13.56%971.02M |
-Long term debt | -0.56%725.3M | -15.89%705.42M | -10.78%741.35M | -28.97%659.42M | -28.97%659.42M | -31.16%729.41M | -27.00%838.67M | -23.83%830.92M | 14.42%928.35M | 14.42%928.35M |
-Long term capital lease obligation | 4.10%40.87M | -9.70%37.06M | -7.46%38.24M | -12.68%37.26M | -12.68%37.26M | -11.34%39.26M | -10.07%41.04M | -12.59%41.32M | -2.45%42.67M | -2.45%42.67M |
Non current deferred liabilities | 21.40%49.54M | 42.02%49.35M | 69.01%52.04M | 47.08%41.25M | 47.08%41.25M | 30.33%40.8M | 0.30%34.75M | -0.96%30.79M | 29.96%28.05M | 29.96%28.05M |
Other non current liabilities | -10.42%11.48M | -5.07%12.28M | -13.78%12.15M | -9.10%12.43M | -9.10%12.43M | -11.46%12.82M | -11.48%12.93M | -7.21%14.1M | -18.40%13.68M | -18.40%13.68M |
Total non current liabilities | 0.59%827.18M | -13.29%804.1M | -8.00%843.78M | -25.91%750.37M | -25.91%750.37M | -28.47%822.29M | -25.44%927.38M | -22.57%917.13M | 13.36%1.01B | 13.36%1.01B |
Total liabilities | -1.54%1.34B | -6.21%1.31B | -6.37%1.27B | -15.70%1.2B | -15.70%1.2B | -18.32%1.37B | -23.38%1.4B | -24.05%1.36B | -4.76%1.42B | -4.76%1.42B |
Shareholders'equity | ||||||||||
Share capital | -3.75%2.29M | -3.84%2.28M | -5.35%2.28M | -1.00%2.38M | -1.00%2.38M | -1.04%2.37M | -1.04%2.37M | 0.54%2.41M | 0.80%2.4M | 0.80%2.4M |
-common stock | -3.75%2.29M | -3.84%2.28M | -5.35%2.28M | -1.00%2.38M | -1.00%2.38M | -1.04%2.37M | -1.04%2.37M | 0.54%2.41M | 0.80%2.4M | 0.80%2.4M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 1.56%1.26B | 3.92%1.21B | 0.63%1.19B | 10.31%1.28B | 10.31%1.28B | 10.06%1.24B | 8.31%1.17B | 13.51%1.19B | 14.02%1.16B | 14.02%1.16B |
Paid-in capital | 6.30%361.8M | 7.68%355.58M | 7.92%350.2M | 9.92%348.74M | 9.92%348.74M | 5.53%340.35M | 5.65%330.23M | 6.34%324.5M | 4.46%317.28M | 4.46%317.28M |
Gains losses not affecting retained earnings | 57.58%3.24M | -141.10%-1.52M | 127.03%2.8M | -57.57%2.1M | -57.57%2.1M | -50.28%2.06M | -48.81%3.69M | -63.34%1.23M | 2,349.01%4.95M | 2,349.01%4.95M |
Total stockholders'equity | 2.64%1.63B | 4.37%1.57B | 2.28%1.55B | 9.98%1.64B | 9.98%1.64B | 8.87%1.59B | 7.40%1.5B | 11.68%1.51B | 12.17%1.49B | 12.17%1.49B |
Total equity | 2.64%1.63B | 4.37%1.57B | 2.28%1.55B | 9.98%1.64B | 9.98%1.64B | 8.87%1.59B | 7.40%1.5B | 11.68%1.51B | 12.17%1.49B | 12.17%1.49B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |